APA (7th ed.) Citation

Jansen, E., Bockstal, V., Herschke, F., Olsson Gisleskog, P., Rinaldi, M., Boerboom, A., . . . Tersago, D. (2026). Characterization of the VHH-Fc construct rimteravimab in healthy adults and patients hospitalized for mild-to-moderate COVID-19: Two Phase 1 randomized clinical trials. PLoS Medicine, 23(5), 1. https://doi.org/10.1371/journal.pmed.1004609

Chicago Style (17th ed.) Citation

Jansen, Ellen, et al. "Characterization of the VHH-Fc Construct Rimteravimab in Healthy Adults and Patients Hospitalized for Mild-to-moderate COVID-19: Two Phase 1 Randomized Clinical Trials." PLoS Medicine 23, no. 5 (2026): 1. https://doi.org/10.1371/journal.pmed.1004609.

MLA (9th ed.) Citation

Jansen, Ellen, et al. "Characterization of the VHH-Fc Construct Rimteravimab in Healthy Adults and Patients Hospitalized for Mild-to-moderate COVID-19: Two Phase 1 Randomized Clinical Trials." PLoS Medicine, vol. 23, no. 5, 2026, p. 1, https://doi.org/10.1371/journal.pmed.1004609.